BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2597866)

  • 1. Cholinergic syndrome following anticholinergic withdrawal in a schizophrenic patient abusing marijuana.
    Tandon R; Dutchak D; Greden JF
    Br J Psychiatry; 1989 May; 154():712-4. PubMed ID: 2597866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinergic syndrome from psychotropic withdrawal in a marijuana abuser.
    Dilsaver SC; Leckrone J; Greden JF
    Psychosomatics; 1984 Aug; 25(8):632-4. PubMed ID: 6332335
    [No Abstract]   [Full Text] [Related]  

  • 3. Protracted vomiting following abrupt cessation of psychotropics: a case report.
    Kalman T; Warner GM
    Can Psychiatr Assoc J; 1978 Apr; 23(3):163-5. PubMed ID: 647615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticholinergic psychosis in a bilingual: a case study.
    Laski E; Taleporos E
    Am J Psychiatry; 1977 Sep; 134(9):1038-40. PubMed ID: 900288
    [No Abstract]   [Full Text] [Related]  

  • 5. Fatal drug-induced heat stroke.
    Forester D
    JACEP; 1978 Jun; 7(6):243-4. PubMed ID: 661049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delirium and stereotypy from anticholinergic antiparkinson drugs.
    Kulik AV; Wilbur R
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(1):75-82. PubMed ID: 7202232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic central anticholinergic toxicity in manic depressive illness mimicking dementia.
    Moreau A; Jones BD; Banno V
    Can J Psychiatry; 1986 May; 31(4):339-41. PubMed ID: 3708528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticholinergic challenge and neuroleptic withdrawal. Changes in dyskinesia and symptom measures.
    Gardos G; Cole JO; Rapkin RM; LaBrie RA; Baquelod E; Moore P; Sovner R; Doyle J
    Arch Gen Psychiatry; 1984 Nov; 41(11):1030-5. PubMed ID: 6149737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative side effects of imipramine, benztropine, or their combination in patients receiving fluphenazine decanoate.
    Siris SG; Rifkin A; Reardon GT; November M
    Am J Psychiatry; 1983 Aug; 140(8):1069-71. PubMed ID: 6346910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholinergic rebounds and withdrawal syndromes.
    Pary RJ; Klontz W; Foxworth JM
    Am J Psychiatry; 1980 Feb; 137(2):261. PubMed ID: 7352599
    [No Abstract]   [Full Text] [Related]  

  • 11. Withdrawal dyskinesia after abrupt cessation of clozapine and benztropine.
    Songer DA; Schulte HM
    J Clin Psychiatry; 1996 Jan; 57(1):40. PubMed ID: 8543548
    [No Abstract]   [Full Text] [Related]  

  • 12. Anticholinergic equivalents and parkinsonism: a model for predicting side-effects of antipsychotic drugs.
    Menkes DB; Clarkson HO; Caradoc-Davies G; Mullen PE
    Int Clin Psychopharmacol; 1987 Jan; 2(1):55-67. PubMed ID: 2889760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esophageal atony and dilatation as a side effect of thiothixene and benztropine.
    Woodring JH; Martin CA; Keefer B
    Hosp Community Psychiatry; 1993 Jul; 44(7):686-8. PubMed ID: 8354511
    [No Abstract]   [Full Text] [Related]  

  • 14. Continuation and maintenance treatment trials of adjunctive imipramine therapy in patients with postpsychotic depression.
    Siris SG; Strahan A
    J Clin Psychiatry; 1988 Nov; 49(11):439-40. PubMed ID: 3182733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The withdrawal of benztropine mesylate in chronic schizophrenic patients.
    Baker LA; Cheng LY; Amara IB
    Br J Psychiatry; 1983 Dec; 143():584-90. PubMed ID: 6362765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic malignant syndrome related to a switch to perospirone and anticholinergic withdrawal.
    Tanii H; Fujita K; Okazaki Y
    Am J Psychiatry; 2006 Mar; 163(3):547-8. PubMed ID: 16513884
    [No Abstract]   [Full Text] [Related]  

  • 17. Concurrent haloperidol withdrawal and benztropine overdose: a case report.
    West RR; Newgreen DB
    Compr Psychiatry; 1978; 19(6):557-60. PubMed ID: 720041
    [No Abstract]   [Full Text] [Related]  

  • 18. Antidepressants in the treatment of post-psychotic depression in schizophrenia: drug interactions and other considerations.
    Siris SG; Sellew AP; Frechen K; Cooper TB; Mandell J; Casey E
    Clin Chem; 1988 May; 34(5):837-40. PubMed ID: 3286051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive imipramine for dysphoric schizophrenic patients with past histories of cannabis abuse.
    Siris SG; Bermanzohn PC; Mason SE; Rifkin A; Alvir JM
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 Jul; 16(4):539-47. PubMed ID: 1641497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of cholinergic supersensitivity in the medical symptoms associated with withdrawal of antipsychotic drugs.
    Luchins DJ; Freed WJ; Wyatt RJ
    Am J Psychiatry; 1980 Nov; 137(11):1395-8. PubMed ID: 6108078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.